ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 972

$1.56M Total Retail Price of All Prescriptions

Rank: 23 out of 972

1,068 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,068 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 1,068 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 21,807 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 1,086 833 1 2
LEVOTHYROXINE SODIUM 1,026 822 2 3
FUROSEMIDE 991 799 3 7
LISINOPRIL 960 741 4 1
METOPROLOL TARTRATE 779 627 5 9
METFORMIN HCL 752 562 6 8
AMLODIPINE BESYLATE 733 584 7 4
OMEPRAZOLE 716 461 8 5
HYDROCODONE-ACETAMINOPHEN 685 423 S3 9 6
WARFARIN SODIUM 658 592 10 12
GABAPENTIN 515 349 11 14
CARVEDILOL 500 372 12 21
POTASSIUM CHLORIDE 495 428 13 13
DONEPEZIL HCL 463 446 14 26
ENALAPRIL MALEATE 458 368 15 50
CITALOPRAM HBR 420 325 16 19
NAMENDA 420 412 16 38
GLIPIZIDE 388 288 18 59
RANITIDINE HCL 360 231 19 24
LOVASTATIN 332 252 20 22
TRAMADOL HCL 310 169 21 15
TRAZODONE HCL 307 162 22 35
HYDROCHLOROTHIAZIDE 298 200 23 10
LOSARTAN POTASSIUM 278 212 24 17
ATORVASTATIN CALCIUM 271 189 25 11
SERTRALINE HCL 249 213 26 25
LANTUS 248 192 27 44
CYCLOBENZAPRINE HCL 245 135 R 28 53
MIRTAZAPINE 243 236 29 46
DIGOXIN 234 209 30 52
CLOPIDOGREL 231 183 31 37
ISOSORBIDE MONONITRATE ER 229 182 32 43
JANUVIA 222 127 33 75
PROAIR HFA 222 91 33 47
NEXIUM 219 104 35 30
ATENOLOL 212 174 36 18
RISPERIDONE 201 175 37 76
PAROXETINE HCL 192 125 38 64
TAMSULOSIN HCL 191 162 39 29
ZOLPIDEM TARTRATE 186 92 40 23
GEMFIBROZIL 183 106 41 93
ALENDRONATE SODIUM 180 153 42 27
SPIRONOLACTONE 179 135 43 54
ADVAIR DISKUS 175 114 44 45
KLOR-CON M20 172 125 45 78
VENLAFAXINE HCL ER 172 127 45 107
SPIRIVA 158 90 47 56
CYMBALTA 154 58 48 49
DIOVAN 151 121 49 48
LANTUS SOLOSTAR 148 61 50 86
PEN NEEDLE 147 67 51 99
METOPROLOL SUCCINATE 146 117 52 16
PLAVIX 144 109 53 55
ALLOPURINOL 138 94 54 28
PRAVASTATIN SODIUM 136 97 55 20
OXYCODONE-ACETAMINOPHEN 134 117 S2 56 80
HYDRALAZINE HCL 132 119 57 69
MELOXICAM 131 75 58 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 87 59 32
DOXAZOSIN MESYLATE 125 114 60 82
LYRICA 124 59 61 113
CARBIDOPA-LEVODOPA 122 108 62 87
DILTIAZEM 24HR CD 120 113 63 74
AMITRIPTYLINE HCL 118 36 R 64 58
PANTOPRAZOLE SODIUM 116 85 65 41
CRESTOR 111 45 66 33
ESCITALOPRAM OXALATE 110 66 67 65
TRICOR 109 33 68 91
AMIODARONE HCL 108 96 69 165
LIDODERM 108 93 69 115
INSULIN SYRINGE 103 74 71 84
NAPROXEN 100 61 72 71
TERAZOSIN HCL 96 60 73 120
METOLAZONE 93 79 74 186
FENOFIBRATE 93 61 74 66
GLYBURIDE 91 63 R 76 70
POLYETHYLENE GLYCOL 3350 90 49 77 67
BUSPIRONE HCL 89 46 78 105
ZETIA 89 64 78 79
CELEBREX 88 47 80 85
SINGULAIR 88 57 80 81
FLUOXETINE HCL 86 45 82 60
AZITHROMYCIN 85 50 83 42
FINASTERIDE 84 84 84 77
FENTANYL 82 72 S2 85 89
ABILIFY 81 76 86 137
NIASPAN 81 48 86 144
PREDNISONE 80 71 88 40
DETROL LA 80 32 88 170
CLONIDINE HCL 74 60 90 57
HUMALOG 73 31 91 150
DOXYCYCLINE HYCLATE 73 59 91 117
ACARBOSE 72 53 93 338
DILTIAZEM HCL 72 59 93 252
OXYCODONE HCL-ACETAMINOPHEN 72 14 S2 93 106
BUPROPION XL 70 34 96 191
QUINAPRIL HCL 70 70 96 95
NOVOLOG FLEXPEN 70 28 96 206
LEVOFLOXACIN 70 56 96 98
CIPROFLOXACIN HCL 68 54 100 63
TRIAMCINOLONE ACETONIDE 67 52 101 134
QUETIAPINE FUMARATE 67 48 101 83
BUPROPION HCL SR 64 17 103 148
OXYBUTYNIN CHLORIDE 64 46 103 97
SYMBICORT 64 40 103 141
VERAPAMIL ER 61 51 106 108
LIPITOR 60 31 107 90
VENLAFAXINE HCL 60 54 107 230
PRIMIDONE 59 43 109 253
VYTORIN 58 35 110 151
COMBIVENT 58 51 110 94
KLOR-CON M10 58 42 110 178
AMOXICILLIN 58 37 110 121
GLIPIZIDE ER 58 47 110 103
SYNTHROID 57 49 115 51
DICYCLOMINE HCL 57 15 115 179
NOVOLOG 56 55 117 100
DICLOFENAC SODIUM 56 31 117 130
ROPINIROLE HCL 55 48 119 72
IBUPROFEN 54 25 120 92
NOVOLIN 70-30 53 53 121 213
CARISOPRODOL 52 0 R 122 110
METHYLPREDNISOLONE 51 30 123 119
OXYCODONE HCL 50 12 S2 124 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.